Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Revenue 2024 to 2034
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Revenue 2024 to 2034
The Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market is projected to expand from USD 4.93 Bn in 2024 to USD 17.31 Bn by 2034, at a CAGR of 13.3%. Growth is driven by increasing disease outbreaks in swine, rising pork production, and growing adoption of effective animal health vaccines worldwide.
Report ID: 10359
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 4.93 Bn
Forecast Year,
USD 17.31 Bn
CAGR, 2025 -
13.37%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Analysis
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Modality 2024 to 2034 (USD )
| Modality | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI/CT/US Platforms | 1.78 | 2.01 | 2.28 | 2.58 | 2.94 | 3.33 | 3.76 | 4.27 | 4.83 | 5.49 | 6.24 |
| X-ray/Fluoroscopy | 0.89 | 1.01 | 1.15 | 1.30 | 1.48 | 1.67 | 1.89 | 2.15 | 2.43 | 2.74 | 3.09 |
| PET/SPECT | 0.79 | 0.89 | 1.01 | 1.14 | 1.29 | 1.46 | 1.66 | 1.87 | 2.11 | 2.39 | 2.73 |
| Software/AI | 0.89 | 1.01 | 1.14 | 1.30 | 1.47 | 1.67 | 1.88 | 2.14 | 2.44 | 2.77 | 3.13 |
| Other | 0.59 | 0.67 | 0.76 | 0.86 | 0.98 | 1.12 | 1.28 | 1.45 | 1.65 | 1.87 | 2.11 |
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 1.68 | 1.91 | 2.17 | 2.47 | 2.81 | 3.18 | 3.59 | 4.05 | 4.61 | 5.23 | 5.91 |
| Cardiology | 0.89 | 1.01 | 1.15 | 1.30 | 1.47 | 1.66 | 1.88 | 2.14 | 2.41 | 2.73 | 3.13 |
| Neurology | 0.79 | 0.89 | 1.00 | 1.13 | 1.28 | 1.46 | 1.66 | 1.89 | 2.14 | 2.44 | 2.75 |
| Orthopedics | 0.59 | 0.67 | 0.76 | 0.86 | 0.97 | 1.10 | 1.25 | 1.43 | 1.62 | 1.84 | 2.07 |
| Others | 0.99 | 1.12 | 1.26 | 1.44 | 1.63 | 1.85 | 2.09 | 2.37 | 2.68 | 3.04 | 3.44 |
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2.86 | 3.24 | 3.67 | 4.14 | 4.71 | 5.35 | 6.04 | 6.85 | 7.77 | 8.81 | 10.01 |
| Imaging Centers | 1.28 | 1.46 | 1.65 | 1.89 | 2.13 | 2.41 | 2.75 | 3.11 | 3.52 | 3.98 | 4.50 |
| Academic/Research | 0.59 | 0.68 | 0.77 | 0.87 | 0.98 | 1.12 | 1.27 | 1.44 | 1.63 | 1.86 | 2.10 |
| Others | 0.20 | 0.22 | 0.26 | 0.29 | 0.33 | 0.37 | 0.42 | 0.48 | 0.55 | 0.62 | 0.70 |
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.07 | 2.34 | 2.65 | 3.00 | 3.38 | 3.87 | 4.39 | 4.99 | 5.63 | 6.35 | 7.16 |
| Europe | 1.38 | 1.57 | 1.78 | 2.02 | 2.31 | 2.61 | 2.94 | 3.33 | 3.79 | 4.30 | 4.90 |
| Asia Pacific | 1.18 | 1.35 | 1.53 | 1.73 | 1.96 | 2.21 | 2.52 | 2.84 | 3.23 | 3.68 | 4.20 |
| Latin America | 0.15 | 0.17 | 0.19 | 0.22 | 0.25 | 0.28 | 0.32 | 0.36 | 0.41 | 0.46 | 0.52 |
| Middle East & Africa | 0.15 | 0.17 | 0.19 | 0.22 | 0.25 | 0.28 | 0.32 | 0.36 | 0.41 | 0.47 | 0.53 |
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
